Boill Healthcare Holdings Limited (01246) submitted its monthly return for the period ended 31 July 2025. According to the announcement, the company’s authorized share capital remained at HKD1,200,000,000, corresponding to 4,800,000,000 ordinary shares with a par value of HKD0.25 each, showing no change from the previous month.

The company’s total issued share capital also stood unchanged at 1,358,000,000 ordinary shares, with no treasury shares reported. Public float requirements were confirmed to have been met, consistent with the applicable 25% minimum threshold. The report further noted an existing share option scheme (adopted on 27 September 2023), under which 135,800,000 ordinary shares remain available for potential issuance. No new shares were issued or repurchased during the reporting month. All required confirmations regarding compliance with regulations and listing requirements were provided in the submission.